Martin Shkreli has been making headlines for jacking up the price of a life-saving drug, but he’s also the owner of a professional League Of Legends team.
Shkreli, owner of Team Imagine, is under fire after his company, Turing Pharmaceutical, acquired and then raised the price of Daraprim by over 5,000 percent. Daraprim is a drug primarily used to treat a parasite infection called toxoplamosis. It’s also used to help patients with compromised immune systems, such as AIDS and cancer patients.
“This isn’t the greedy drug company trying to gouge patients, it is us trying to stay in business,” Shkreli stated, defending the price hike.
There has been an outcry of those wondering if Riot, the developer behind League Of Legends, should step in and make a statement on the situation.